Health
Subset of COVID-19 patients have increased bleeding risk – EurekAlert
A new potential biomarker raises concerns over the current standard for treating COVID-19 induced blood clots with high dose blood thinners.
The human body strives to keep itself in homeostasis, or balance. When blood clots are created, the body’s innate response is to break the clots down to prevent significant health problems from arising.
Research has found that patients with COVID-19 are prone to serious blood clotting. This is why many patients receive high dose anticoagulants as part of their treatment.
But a new study in Scientific Reports, led by senior author Daniel Lawrence, Ph.D., a Professor of Basic Research in Cardiovascular…
-
General20 hours agoAlleged Croydon Park gunman Artemios Mintzas charged with 25 offences
-
Noosa News21 hours agoPerth Royal Show attendance slumps to 10-year low
-
Noosa News6 hours agoSuncorp Stadium upgrades to rival Sydney as seat capacity and infrastructure prioritised
-
General18 hours agoAn open letter to pro-Palestinian protesters